Authors: Luce, BR Zangwill, KM Palmer, CS Mendelman, PM Yan, LH Wolff, MC Cho, IS Marcy, SM Iacuzio, D Belshe, RB

Citation: Br. Luce et al., Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children, PEDIATRICS, 108(2), 2001, pp. NIL_22-NIL_29

Authors: Belshe, RB Gruber, WC Mendelman, PM Cho, I Reisinger, K Block, SL Wittes, J Iacuzio, D Piedra, P Treanor, J King, J Kotloff, K Bernstein, DI Hayden, FG Zangwill, K Yan, LH Wolff, M

Citation: Rb. Belshe et al., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, J PEDIAT, 136(2), 2000, pp. 168-175

Authors: King, JC Treanor, J Fast, PE Wolff, M Yan, LH Iacuzio, D Readmond, B O'Brien, D Mallon, K Highsmith, WE Lambert, JS Belshe, RB

Citation: Jc. King et al., Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults, J INFEC DIS, 181(2), 2000, pp. 725-728

Authors: Treanor, JJ Kotloff, K Betts, RF Belshe, R Newman, F Iacuzio, D Wittes, J Bryant, M

Citation: Jj. Treanor et al., Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV)influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses, VACCINE, 18(9-10), 1999, pp. 899-906